Reinstatement of extinguished amphetamine self-administration by 3,4-methylenedioxymethamphetamine (MDMA) and its enantiomers in rhesus monkeys

Psychopharmacology

Volumn 210, Issue 1, 2010, Pages 75-83

  McClung, Jessica ^a   Fantegrossi, William ^a,b   Howell, Leonard L ^a,c  

^a EMORY UNIVERSITY   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amphetamine; BZP; MDMA; Reinstatement; Rhesus monkey

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; AMPHETAMINE; DOPAMINE; FENFLURAMINE; FLUOXETINE; N BENZYLPIPERAZINE; PIPERAZINE DERIVATIVE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG DEPENDENCE; DRUG DISCRIMINATION; FEMALE; MALE; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SEROTONINERGIC SYSTEM;

AMPHETAMINE; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MACACA MULATTA; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; REACTION TIME; REINFORCEMENT SCHEDULE; SELF ADMINISTRATION; STEREOISOMERISM;

EID: 77955570057     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-010-1818-7     Document Type: Article

References (53)

1. Baker LE, Taylor MM (1997) Assessment of the MDA and MDMA optical isomers in a stimulant-hallucinogen discrimination. Pharmacol Biochem Behav 57:737-748
2. Baker LE, Broadbent J, Michael EK, Matthews PK, Metosh CA, Saunders RB, West WB, Appel JB (1995) Assessment of the discriminative stimulus effects of the optical isomers of ecstasy (3, 4-methylenedioxymethamphetamine; MDMA). Behav Pharmacol 6:263-275
3. Baker LE, Virden TB, Miller ME, Sullivan CL (1997) Time course analysis of the discriminative stimulus effects of the optical isomers of 3, 4-methylenedioxymethamphetamine (MDMA). Pharmacol Biochem Behav 58:505-516
4. Battaglia G, De Souza EB (1989) Pharmacologic profile of amphetamine derivatives at various brain recognition sites: selective effects on serotonergic systems. NIDA Res Monogr 94:240-258
5. Baumann MH, Clark RD, Budzynski AG, Partilla JS, Blough BE, Rothman RB (2004) Effects of "Legal X" piperazine analogs on dopamine and serotonin release in rat brain. Ann NY Acad Sci 1025:189-197
6. Baumann MH, Clark RD, Budzynski AG, Partilla JS, Blough BE, Rothman RB (2005) N-Substituted piperazines abused by humans mimic the molecular mechanism of 3, 4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy'). Neuropsychopharmacology 30:550-560
7. Brennan KA, Lake B, Hely LS, Jones K, Gittings D, Colussi-Mas J, Fitzmaurice PS, Lea RA, Schenk S (2007) N-benzylpiperazine has characteristics of a drug of abuse. Behav Pharmacol 18:785-790
8. Callaway CW, Wing LL, Geyer MA (1990) Serotonin release contributes to the locomotor stimulant effects of 3, 4-methylenedioxymethamphetamine in rats. J Pharmacol Exp Ther 254:456-464
9. Cami J, Farre M, Mas M, Roset PN, Poudevida S, Mas A, San L, de la Torre R (2000) Human pharmacology of 3, 4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects. J Clin Psychopharmacol 20:455-466
10. Chait LD, Uhlenhuth EH, Johanson CE (1986) Human drug discrimination: D-amphetamine and other anorectics. NIDA Res Monogr 67:161-167
11. de Wit H, Stewart J (1981) Reinstatement of cocaine-reinforced responding in the rat. Psychopharmacology (Berl) 75:134-143
12. Easton N, Marsden CA (2006) Ecstasy: are animal data consistent between species and can they translate to humans? J Psychopharmacol 20:194-210
13. Evans SM, Johanson CE (1986) Discriminative stimulus properties of (+/-)-3, 4-methylenedioxymethamphetamine and (+/-)-3, 4- methylenedioxyamphetamine in pigeons. Drug Alcohol Depend 18:159-164
14. Fantegrossi WE, Godlewski T, Karabenick RL, Stephens JM, Ullrich T, Rice KC, Woods JH (2003) Pharmacological characterization of the effects of 3, 4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice. Psychopharmacology (Berl) 166:202-211
15. Fantegrossi WE, Winger G, Woods JH, Woolverton WL, Coop A (2005) Reinforcing and discriminative stimulus effects of 1-benzylpiperazine and trifluoromethylphenylpiperazine in rhesus monkeys. Drug Alcohol Depend 77:161-168
16. Fantegrossi WE, Murai N, Mathuna BO, Pizarro N, de la Torre R (2009) Discriminative stimulus effects of 3, 4-methylenedioxymethamphetamine and its enantiomers in mice: pharmacokinetic considerations. J Pharmacol Exp Ther 329:1006-1015
17. Gerber GJ, Stretch R (1975) Drug-induced reinstatement of extinguished self-administration behavior in monkeys. Pharmacol Biochem Behav 3:1055-1061
18. Glennon RA (1989) Stimulus properties of hallucinogenic phenalkylamines and related designer drugs: formulation of structureactivity relationships. NIDA Res Monogr 94:43-67
19. Glennon RA, Misenheimer BR (1989) Stimulus effects of Nmonoethyl-1-(3, 4-methylenedioxyphenyl)-2-aminopropane (MDE) and N-hydroxy-1-(3, 4-methylenedioxyphenyl)-2-aminopropane (N-OH MDA) in rats trained to discriminate MDMA from saline. Pharmacol Biochem Behav 33:909-912
20. Glennon RA, Young R (1984) MDA: a psychoactive agent with dual stimulus effects. Life Sci 34:379-383
21. Glennon RA, Yousif M, Patrick G (1988) Stimulus properties of 1-(3, 4-methylenedioxyphenyl)-2-aminopropane (MDA) analogs. Pharmacol Biochem Behav 29:443-449
22. Gold LH, Koob GF (1989) MDMA produces stimulant-like conditioned locomotor activity. Psychopharmacology (Berl) 99:352-356
23. Goodwin AK, Baker LE (2000) A three-choice discrimination procedure dissociates the discriminative stimulus effects of damphetamine and (±)-MDMA in rats. Exp Clin Psychopharmacol 8:415-423
24. Hiramatsu M, Nabeshima T, Kameyama T, Maeda Y, Cho AK (1989) The effect of optical isomers of 3, 4-methylendioxymethamphetamine (MDMA) on stereotyped behavior in rats. Pharmacol Biochem Behav 33:343-347
25. Howell LL, Wilcox KM (2001) The dopamine transporter and cocaine medication development: drug self-administration in nonhuman primates. J Pharmacol Exp Ther 298:1-6
26. Johanson CE, Kilbey M, Gatchalian K, Tancer M (2006) Discriminative stimulus effects of 3, 4-methylenedioxymethamphetamine (MDMA) in humans trained to discriminate among D-amphetamine, meta-chlorophenylpiperazine and placebo. Drug Alcohol Depend 81:27-36
27. Kamien JB, Johanson CE, Schuster CR, Woolverton WL (1986) The effects of (+/-)-methylenedioxymethamphetamine and (+/-) - methylenedioxyamphetamine in monkeys trained to discriminate (+)-amphetamine from saline. Drug Alcohol Depend 18:139-147
28. Liechti ME, Vollenweider FX (2001) Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies. Hum Psychopharmacol Clin Exp 16:589-598
29. Liechti ME, Baumann C, Gamma A, Vollenweider FX (2000) Acute psychological effects of 3, 4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram. Neuropsychopharmacology 22:513-521
30. Lin J, Bangs N, Lee H, Kydd R, Russell B (2009) Determining the subjective and physiological effects of BZP on human females. Psychopharmacology 207:439-446
31. McCreary AC, Filip M, Cunningham KA (2003) Discriminative stimulus properties of (+/-)-fenfluramine: the role of 5-HT2 receptor subtypes. Behav Neurosci 117:212-221
32. McNamara MG, Kelly JP, Leonard BE (1995) Some behavioural and neurochemical aspects of subacute (±) 3, 4-methylenedioxymethamphetamine administration in rats. Pharmacol Biochem Behav 52:479-484
33. Murnane KS, Murai N, Howell LL, Fantegrossi WE (2009) Discriminative stimulus effects of psychostimulants and hallucinogens in S (+)-3, 4-methylenedioxymethamphetamine (MDMA) and R (-)-MDMA trained mice. J Pharmacol Exp Ther 331:717-723
34. Negus SS, Baumann MH, Rothman RB, Mello NK, Blough BE (2009) Selective suppression of cocaine-versus food-maintained responding by monoamine releasers in rhesus monkeys: benzylpiperazine, (+) phenmetrazine, and 4-benzylpiperidine. J Pharmacol Exp Ther 329:272-281
35. Oberlender R, Nichols DE (1988) Drug discrimination studies with MDMA and amphetamine. Psychopharmacology (Berl) 95:71-76
36. Paulus MP, Geyer MA (1992) The effects of MDMA and other methylenedioxy-substituted phenylalkylamines on the structure of rat locomotor activity. Neuropsychopharmacology 7:15-31
37. Rudnick G, Wall SC (1992) The molecular mechanism of "ecstasy" [3, 4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release. Proc Natl Acad Sci USA 89:1817-1821
38. Schechter MD (1986) Discriminative profile of MDMA. Pharmacol Biochem Behav 24:1533-1537
39. Schechter MD (1987) MDMA as a discriminative stimulus: isomeric comparisons. Pharmacol Biochem Behav 27:41-44
40. Schechter MD (1988) Serotonergic-dopaminergic mediation of 3, 4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Biochem Behav 31:817-824
41. Schechter MD, Rosecrans JA (1973) D-amphetamine as a discriminative cue: drugs with similar stimulus properties. Eur J Pharmacol 21:212-216
42. Slikker W Jr, Brocco MJ, Killam KF Jr (1984) Reinstatement of responding maintained by cocaine or thiamylal. J Pharmacol Exp Ther 228:43-52
43. Slikker W, Holson RR, Ali SF, Kolta MG, Paule MG, Scallet AC, McMillan DE, Bailey JR, Hong JS, Scalzo FM (1989) Behavioral and neurochemical effects of orally administered MDMA in the rodent and nonhuman primate. Neurotoxicology 10:529-542
44. Souza D, Kelly JP, Harkin AJ, Leonard BE (1997) An appraisal of the pharmacological and toxicological effects of a single oral administration of 3, 4-methylenedioxymethamphetamine (MDMA) in the rat. Pharmacol Toxicol 80:207-210
45. Steele TD, Nichols DE, Yim GK (1987) Stereochemical effects of 3, 4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain. Biochem Pharmacol 36:2297-2303
46. Stein DJ, Rink J (1999) Effects of "Ecstasy" blocked by serotonin reuptake inhibitors. J Clin Psychiatry 60:485
47. Stolerman IP (1993) Components of drug dependence: reinforcement, discrimination and adaptation. Biochem Soc Symp 59:1-12
48. Stretch R, Gerber GJ (1973) Drug-induced reinstatement of amphetamine self-administration behaviour in monkeys. Can J Psychol 27:168-177
49. Tancer ME, Johanson CE (2001) The subjective effects of MDMA and mCPP in moderate MDMA users. Drug Alcohol Depend 65:97-101
50. Tancer M, Johanson CE (2003) Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with D-amphetamine and mCPP. Drug Alcohol Depend 72:33-44
51. Wee S, Anderson KG, Baumann MH, Rothman RB, Blough BE, Woolverton WL (2005) Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs. J Pharmacol Exp Ther 313:848-854
52. White FJ, Appel JB (1981) A neuropharmacological analysis of the discriminative stimulus properties of fenfluramine. Psychopharmacology 73:110-115
53. Woolverton WL, Wang Z (2004) Relationship between injection duration, transporter occupancy and reinforcing strength of cocaine. Eur J Pharmacol 486:251-257